z-logo
open-access-imgOpen Access
Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
Author(s) -
Jean-Christophe Lagier,
Matthieu Million,
Sébastien Cortaredona,
Léa Delorme,
Philippe Colson,
PierreEdouard Fournier,
Philippe Brouqui,
Didier Raoult,
Philippe Parola
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s364022
Subject(s) - medicine , hydroxychloroquine , azithromycin , context (archaeology) , retrospective cohort study , intensive care unit , cohort , pediatrics , covid-19 , disease , antibiotics , paleontology , infectious disease (medical specialty) , microbiology and biotechnology , biology
We evaluated the 6-week mortality of SARS-CoV-2 hospitalized patients treated using a standardized protocol in 2020 in Marseille, France.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here